Flibanserin Versus Placebo in Premenopausal Women With HSDD (Q61917933)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Flibanserin Versus Placebo in Premenopausal Women With HSDD |
clinical trial |
Statements
A Twenty-Four Week, Randomized, Double-Blind, Placebo Controlled, Safety and Efficacy Trial of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in Premenopausal European Women With Hypoactive Sexual Desire Disorder (English)
0 references
June 2007
0 references
March 2009
0 references
945
0 references
18 year
0 references